Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study

Background: Hepatic steatosis is associated with obesity and type II diabetes. Proton magnetic resonance spectroscopy (1H MRS) is a non-invasive method for measurement of tissue fat content, including intrahepatocellular lipids (IHCL) and intramyocellular lipids (IMCL). Patients and methods: We used...

Full description

Saved in:
Bibliographic Details
Published inGut Vol. 54; no. 1; pp. 122 - 127
Main Authors Thomas, E L, Hamilton, G, Patel, N, O’Dwyer, R, Doré, C J, Goldin, R D, Bell, J D, Taylor-Robinson, S D
Format Journal Article
LanguageEnglish
Published London BMJ Publishing Group Ltd and British Society of Gastroenterology 01.01.2005
BMJ
BMJ Publishing Group LTD
Copyright 2005 by Gut
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background: Hepatic steatosis is associated with obesity and type II diabetes. Proton magnetic resonance spectroscopy (1H MRS) is a non-invasive method for measurement of tissue fat content, including intrahepatocellular lipids (IHCL) and intramyocellular lipids (IMCL). Patients and methods: We used 1H MRS and whole body magnetic resonance imaging (MRI) to assess the relationship between IHCL accumulation, total body adipose tissue (AT) content/distribution, and IMCL content in 11 subjects with biopsy proven hepatic steatosis and 23 normal volunteers. Results: IHCL signals were detectable in all subjects but were significantly greater in hepatic steatosis (geometric mean (GM) 11.5 (interquartile range (IQR) 7.0–39.0)) than in normal volunteers (GM 2.7 (IQR 0.7–9.3); p = 0.02). In the study group as a whole, IHCL levels were significantly greater in overweight compared with lean subjects (body mass index (BMI) >25 kg/m2 (n = 23): GM 7.7 (IQR 4.0–28.6) v BMI <25 kg/m2 (n = 11): GM 1.3 (IQR 0.3–3.6; p = 0.004)). There was a significant association between IHCL content and indices of overall obesity (expressed as a percentage of body weight) for total body fat (p = 0.001), total subcutaneous AT (p = 0.007), and central obesity (subcutaneous abdominal AT (p = 0.001) and intra-abdominal AT (p = 0.001)), after allowing for sex and age. No correlation between IHCL content and IMCL was observed. A significant correlation was observed between serum alanine aminotransferase and liver fat content (r = 0.57, p = 0.006). Conclusions: Our results suggest that hepatic steatosis appears to be closely related to body adiposity, especially central obesity. MRS may be a useful method for monitoring IHCL in future interventional studies.
Bibliography:href:gutjnl-54-122.pdf
PMID:15591516
istex:9C24C1E737DE8C451A956D43106550613A470EA3
Correspondence to:
 Dr J D Bell
 MRI Unit, Hammersmith Hospital, Du Cane Rd, London W12 0HS, UK; jimmy.bell@csc.mrc.ac.uk
local:0540122
ark:/67375/NVC-TBNLD8TT-V
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Conflict of interest: None declared.
Correspondence to: …Dr J D Bell …MRI Unit, Hammersmith Hospital, Du Cane Rd, London W12 0HS, UK; jimmy.bell@csc.mrc.ac.uk
ISSN:0017-5749
1468-3288
1458-3288
DOI:10.1136/gut.2003.036566